Sorafenib analogue SC-60 induces apoptosis through the SHP-1/STAT3 pathway and enhances docetaxel cytotoxicity in triple-negative breast cancer cells-Reference-Cited by-全球学者库

Sorafenib analogue SC-60 induces apoptosis through the SHP-1/STAT3 pathway and enhances docetaxel cytotoxicity in triple-negative breast cancer cells

Published:2017-02-07 Issue:3 Volume:11 Page:266-279
ISSN:1574-7891
Container-title:Molecular Oncology
language:en
Short-container-title:Mol Oncol

Author:

Liu Chun-Yu¹²³,Su Jung-Chen⁴⁵,Huang Tzu-Ting¹²,Chu Pei-Yi⁶⁷,Huang Chun-Teng³⁸,Wang Wan-Lun⁹,Lee Chia-Han²,Lau Ka-Yi²,Tsai Wen-Chun²,Yang Hsiu-Ping²,Shiau Chung-Wai⁴,Tseng Ling-Ming¹³⁹,Chen Kuen-Feng¹⁰¹¹^ORCID

Affiliation:

1. Comprehensive Breast Health Center; Taipei Veterans General Hospital; Taiwan

2. Division of Medical Oncology; Department of Oncology; Taipei Veterans General Hospital; Taiwan

3. School of Medicine; National Yang-Ming University; Taipei Taiwan

4. Institute of Biopharmaceutical Sciences; National Yang-Ming University; Taipei Taiwan

5. Department of Clinical Laboratory Sciences and Medical Biotechnology; National Taiwan University; Taipei Taiwan

6. Department of Pathology; Show Chwan Memorial Hospital; Changhua Taiwan

7. School of Medicine; College of Medicine; Fu-Jen Catholic University; Xinzhuang New Taipei City Taiwan

8. Division of Hematology & Oncology; Department of Medicine; Yang-Ming Branch of Taipei City Hospital; Taiwan

9. Department of Surgery; Taipei Veterans General Hospital; Taiwan

10. Department of Medical Research; National Taiwan University Hospital; Taipei Taiwan

11. National Taiwan University College of Medicine; Taipei Taiwan

Funder

Taiwan Clinical Oncology Research Foundation

Yen Tjing Ling Medical Foundation

Ministry of Science and Technology, Taiwan

National Health Research Institutes

Yang-Ming Branch of Taipei City Hospital

Taipei Veterans General Hospital

TVGH-NTUH Joint Research Program

National Taiwan University Hospital

Ministry of Health and Welfare

Cancer Research at Taipei Veterans General

Chong Hin Loon Memorial Cancer

National Yang-Ming University

Publisher

Wiley

Subject

Cancer Research,Genetics,Molecular Medicine,General Medicine,Oncology

Reference64 articles.

1. alpha-Haloacetophenone derivatives as photoreversible covalent inhibitors of protein tyrosine phosphatases;Arabaci;J Am Chem Soc,1999

2. Sustained MAP kinase activation is required for the expression of cyclin D1, p21Cip1 and a subset of AP-1 proteins in CCL39 cells;Balmanno;Oncogene,1999

3. Constitutive activation of STAT3 in breast cancer cells: a review;Banerjee;Int J Cancer,2015

4. Stat3 is tyrosine-phosphorylated through the interleukin-6/glycoprotein 130/Janus kinase pathway in breast cancer;Berishaj;Breast Cancer Res,2007

5. Expression of estrogen receptor alpha increases leptin-induced STAT3 activity in breast cancer cells;Binai;Int J Cancer,2010

Cited by 29 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Consideration of SHP-1 as a Molecular Target for Tumor Therapy;International Journal of Molecular Sciences;2023-12-26

2. Development and validation of an inflammatory response-related signature in triple negative breast cancer for predicting prognosis and immunotherapy;Frontiers in Oncology;2023-06-15

3. Integrated molecular analyses of an interferon-γ based subtype with regard to outcome, immune characteristics, and immunotherapy in bladder cancer and experimental verification;Heliyon;2022-12

4. Novel thieno[2,3-b]quinoline-procaine hybrid molecules: A new class of allosteric SHP-1 activators evolved from PTP1B inhibitors;Chinese Chemical Letters;2022-12

5. Prognostic Signature Development on the Basis of Macrophage Phagocytosis-Mediated Oxidative Phosphorylation in Bladder Cancer;Oxidative Medicine and Cellular Longevity;2022-09-29